Communicable DiseasesSnowNCT01232686
Snow Disease Surveillance System Study
A study testing Online disease surveillance data access in people with Communicable Diseases, run by University Hospital of North Norway.
Trial summary
The study investigates whether shared online access to epidemiological data for general practitioners, disease prevention officers, emergency care services and microbiology laboratories changes clinical practice with regard to testing, diagnosing and treatment of communicable diseases. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Communicable Diseases
- What is being tested?
- Online disease surveillance data access
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- No sites listed yet
- Study dates
- Oct 2010to Dec 2012
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Volunteering General Practitioner (GP) working in a GP office
Who cannot join
- The GP does not use a Electronic Patient Record (EPR) system
About this study
The study investigates whether shared online access to epidemiological data for general practitioners, disease prevention officers, emergency care services and microbiology laboratories changes clinical practice with regard to testing, diagnosing and treatment of communicable diseases. The main hypothesis is that "online access for general practitioner to epidemiological data about communicable diseases changes clinical practice for testing, diagnosing and treatment of communicable diseases".
Read the detailed description
We will collect data from general practitioners (GP) offices by installing local data extraction solutions. Each installation will build a local anonymous database of GP consultations extracted from the local electronic patient record (EPR) system. These anonymous data records will be used to produce local disease statistics before they are exported to a centralized server available in the Norwegian Health network. The centralized server will produce daily reports about the epidemiological situation in the patient population. We will combine the syndromic data from the GP offices with data from the microbiology laboratories on the hospitals that covers the study areas. The epidemiological data will be made available to the intervention areas in the study through web based and customized client applications.
By using data extracted from the GP offices EPR databases and the microbiology laboratories we will investigate the study hypothesis.
- Conditions
- Communicable Diseases
- Being tested
- Online disease surveillance data access
- Keywords
- Communicable Diseases, Epidemiology, Population surveillance, Computerized Medical Record, Data collection
- Medical subject headings
- Communicable Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Online disease surveillance data accessOther
In the intervention areas we will give the study participants online access to the Snow disease surveillance system. The system will provide data about the incidents of respiratory and gastrointestinal communicable diseases in the patient population.
| Study group | Role | What they receive |
|---|---|---|
| Control area | No intervention | In the control areas we will monitor the prevalence and treatment of communicable diseases without giving the participants online access to disease surveillance information |
| Intervention area | Experimental | In these areas we will give study participants online access to epidemiological data for communicable diseases Receives: Other: Online disease surveillance data access |
What is being measured
The primary outcome is the main question the study is designed to answer.
Earlier diagnosis and treatment for communicable diseases
General practitioners (GP) have three possible decisions in a consultation with a patient; 1) treat on suspicion, 2) take a sample, 3) wait and see whether the patient recovers or get worse, or 4) a combination of 1 and 2.
In situations with decision 3 (wait and see) the patient may return to a consultation later on.
The hypothesis is that online access to epidemiological data from the local patient population will enable GPs to make the right decision more often based on knowledge about the epidemiological situation in the patient population.
Measured: Measured at the end of the data collection period, approx. 1.5 year. (December 2012)
Secondary outcomes (3)
Earlier detection of local disease outbreaks
Syndromic surveillance enables earlier detection of local disease outbreaks compared to traditional laboratory based surveillance. We will record the time of disease outbreak detection in both intervention and control areas and compare.
Measured: Measured at the end of the data collection period, approx. 1.5 year. (December 2012)
Lower number of infected during disease outbreaks
We will compare the number of infected in the intervention and control areas. The hypothesis is that the intervention areas will have fewer infected compared to the control areas.
Measured: Measured at the end of the data collection period, approx. 1.5 year. (December 2012)
Impact on health service costs
We will measure the cost related to communicable diseases in the control and intervention areas. Our prediction is that it will change.
Measured: Measured at the end of the data collection period, approx. 1.5 year. (December 2012)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Nov 2010 (estimated)
- Study startOct 2010
- Primary completionDec 2012
- Study completionDec 2012
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Communicable DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital of North Norway
- Sponsor type
- University, hospital or other
- Collaborators
- University of Tromso, The Royal Norwegian Ministry of Health, Norwegian Health Network (state owned enterprise)
- Responsible party
- Sponsor
- Investigators
- Johan Gustav Bellika, PhD, Principal investigator, University of Tromsø, Department of Computer Science
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01232686
- Sponsor's protocol ID
- ID 3746/ HST954-10
- Acronym
- Snow
- Status last verified
- Dec 2015
- First submitted
- 15 Oct 2010
- Last updated
- 16 Feb 2017
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Feb 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Snow Disease Surveillance System Study
- ClinicalTrials.gov ID
- NCT01232686
- Acronym / sponsor ID
- Snow / ID 3746/ HST954-10
- Conditions
- Communicable Diseases
- Keywords
- Communicable Diseases, Epidemiology, Population surveillance, Computerized Medical Record, Data collection
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- University Hospital of North NorwayUniversity, hospital or other
- Collaborators
- University of Tromso, The Royal Norwegian Ministry of Health, Norwegian Health Network (state owned enterprise)
- Study start
- Oct 2010
- Primary completion
- Dec 2012 (actual)
- Study completion
- Dec 2012 (actual)
- First posted
- 2 Nov 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study investigates whether shared online access to epidemiological data for general practitioners, disease prevention officers, emergency care services and microbiology laboratories changes clinical practice with regard to testing, diagnosing and treatment of communicable diseases. The main hypothesis is that "online access for general practitioner to epidemiological data about communicable diseases changes clinical practice for testing, diagnosing and treatment of communicable diseases".
Detailed description
We will collect data from general practitioners (GP) offices by installing local data extraction solutions. Each installation will build a local anonymous database of GP consultations extracted from the local electronic patient record (EPR) system. These anonymous data records will be used to produce local disease statistics before they are exported to a centralized server available in the Norwegian Health network. The centralized server will produce daily reports about the epidemiological situation in the patient population. We will combine the syndromic data from the GP offices with data from the microbiology laboratories on the hospitals that covers the study areas. The epidemiological data will be made available to the intervention areas in the study through web based and customized client applications.
By using data extracted from the GP offices EPR databases and the microbiology laboratories we will investigate the study hypothesis.
Study design
- Primary purpose
- Health services research
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Control area | No intervention | –In the control areas we will monitor the prevalence and treatment of communicable diseases without giving the participants online access to disease surveillance information |
| Intervention area | Experimental | Other: Online disease surveillance data accessIn these areas we will give study participants online access to epidemiological data for communicable diseases |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Volunteering General Practitioner (GP) working in a GP office
Key exclusion criteria (1 listed)
- The GP does not use a Electronic Patient Record (EPR) system
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Online disease surveillance data accessIn the intervention areas we will give the study participants online access to the Snow disease surveillance system. The system will provide data about the incidents of respiratory and gastrointestinal communicable diseases in the patient population. | Other | Intervention area |
Primary outcome
Earlier diagnosis and treatment for communicable diseases
Time frame: Measured at the end of the data collection period, approx. 1.5 year. (December 2012)
General practitioners (GP) have three possible decisions in a consultation with a patient; 1) treat on suspicion, 2) take a sample, 3) wait and see whether the patient recovers or get worse, or 4) a combination of 1 and 2. In situations with decision 3 (wait and see) the patient may return to a consultation later on. The hypothesis is that online access to epidemiological data from the local patient population will enable GPs to make the right decision more often based on knowledge about the epidemiological situation in the patient population.
3 secondary outcomes
Earlier detection of local disease outbreaks
Time frame: Measured at the end of the data collection period, approx. 1.5 year. (December 2012)
Lower number of infected during disease outbreaks
Time frame: Measured at the end of the data collection period, approx. 1.5 year. (December 2012)
Impact on health service costs
Time frame: Measured at the end of the data collection period, approx. 1.5 year. (December 2012)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Feb 2017.
Related trials for Communicable Diseases
Not yet recruitingPhase 3
Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children
Recurrent Respiratory Papillomatosis (RRP), Juvenile-onset Recurrent Respiratory Papillomatosis
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Not yet recruitingPhase 2
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)
Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV)
Not yet recruiting
Vocxi Breath Analyzer Study in Pediatric Respiratory Infection
Acute Respiratory Illness, Viral Respiratory Infection
RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Invasive Mold Infections
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Johan Gustav Bellika, PhD principal investigator
University of Tromsø, Department of Computer Science
Questions about this trial
What is this clinical trial studying?
A study testing Online disease surveillance data access in people with Communicable Diseases, run by University Hospital of North Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Earlier diagnosis and treatment for communicable diseases (time frame: Measured at the end of the data collection period, approx. 1.5 year. (December 2012)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2017.